Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Irum Khan"'
Autor:
Suman Kambhampati, Iskra Pusic, James M. Foran, John G. Edwards, John Lister, Farhad Ravandi, John M. Pagel, Charalambos Andreadis, Camille N. Abboud, Swapna Panuganti, Lois Kellerman, Martin S. Tallman, Richard David Mamelok, Delong Liu, Lawrence E. Morris, Saar Gill, Alicia Wong, Jack W. Hsu, Gary J. Schiller, Pinkal Desai, Hagop M. Kantarjian, Melham M. Solh, Irum Khan, Olga Frankfurt, Rodney Van Syoc, Patrick J. Stiff, Ramkumar Mandalam, Janice M. Brown, Wendy Stock, Luke P. Akard, Celalettin Ustun, Matthew J Wieduwilt
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 39, iss 29
PURPOSE Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyelocel-L is a universal, allogeneic myeloid progenitor cell product being studied to reduce infection durin
Autor:
Jan Philipp Bewersdorf, Blanca Boluda, David Martínez-Cuadrón, Maximilian Stahl, Nikolai A. Podoltsev, Raphael Itzykson, Ellen K. Ritchie, Brendan Yoo, Thomas Cluzeau, Emma Rabinovich, Amer M. Zeidan, Florence Rabian, Ulrich Germing, Rebeca Rodríguez-Veiga, Rory M. Shallis, Steven D. Gore, Isabel Cano, Selina M. Luger, Mikkael A. Sekeres, Christine M. McMahon, Amir T. Fathi, Irum Khan, Evelyn Acuña-Cruz, Vijaya Raj Bhatt, Judith Neukirchen, Sudipto Mukherjee, Mar Tormo, Etienne Lengliné, Emmanuel Raffoux, Pau Montesinos, Wei Wei, Gail J. Roboz, Jayadev Manikkam Umakanthan, Heiko Konig, Adam R. Miller, Andrew M. Brunner
Publikováno v:
Leukemia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
LEUKEMIA
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
LEUKEMIA
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Hyperleukocytosis in acute myeloid leukemia (AML) is associated with inferior outcomes. There is limited high quality evidence to support the benefits of leukapheresis. We retrospectively collected data from patients with newly-diagnosed AML who pres
Autor:
Santosh L. Saraf, Pritesh R. Patel, Nadim Mahmud, Karen Sweiss, David Peace, Annie L. Oh, Robert E. Molokie, Matthew Koshy, Victor R. Gordeuk, Shivi Jain, Michel Gowhari, Sally Campbell-Lee, Damiano Rondelli, John G. Quigley, Irum Khan
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:1759-1765
We report on the screening and development of haploidentical hematopoietic stem cell transplantation (HSCT) for adult patients with clinically aggressive sickle cell disease (SCD) at our institution. Of 50 adult SCD patients referred for HSCT between
Autor:
Ivy Elizabeth, Abraham, Anand Ashwin, Patel, Heidy, Wang, John Patrick, Galvin, Olga, Frankfurt, Li, Liu, Irum, Khan
Publikováno v:
Cancer causescontrol : CCC. 32(7)
Racial disparities in acute myeloid leukemia (AML) have been reported but the relative contribution of disease versus patient-specific factors including comorbidities and access to care is unclear.We conducted a retrospective analysis of patient char
Autor:
Vaibhav Agrawal, Saad Arain, Gregory S. Calip, Aysenur Esen, Kirk E. Cahill, Shawn Griffin, Olatoyosi Odenike, Ardaman Shergill, Pritesh R. Patel, Heiko Konig, Wendy Stock, Sonia Christian, Karen Sweiss, John G. Quigley, Irum Khan
Publikováno v:
Am J Hematol
Relapsed or refractory acute myeloid leukemia (R/R AML) has a poor prognosis and is best treated with salvage chemotherapy as a bridge to allogeneic stem cell transplant (alloSCT). However, the optimal salvage therapy remains unknown. Here we compare
Autor:
Jennifer L. Anderson, Christina Mactal-Haaf, Pritesh R. Patel, Annie Oh, Santosh L. Saraf, Scott Wirth, Karen Sweiss, Damiano Rondelli, John G. Quigley, Irum Khan
Publikováno v:
Bone Marrow Transplantation. 53:300-306
Prophylaxis for Pneumocystis jirovecii pneumonia (PJP) is recommended for patients undergoing hematopoietic stem cell transplantation (HSCT) or intensive chemotherapy. Trimethoprim-sulfamethoxazole and inhaled pentamidine are used frequently, but are
Autor:
Irum Khan, Nandini Kalakota, Andrei L. Gartel, Olga Frankfurt, Marianna Halasi, Nadim Mahmud, Anand Patel, Yi Hua Chen, Nathan Aardsma, Li Liu, Rachael Schultz, John D. Crispino
Publikováno v:
JCI Insight
Acute myeloid leukemia (AML) patients with NPM1 mutations demonstrate a superior response to standard chemotherapy treatment. Our previous work has shown that these favorable outcomes are linked to the cytoplasmic relocalization and inactivation of F
Autor:
Pritesh, Patel, Annie L, Oh, Matthew, Koshy, Karen, Sweiss, Santosh L, Saraf, John G, Quigley, Irum, Khan, Nadim, Mahmud, Eileen, Hacker, Howard, Ozer, David J, Peace, Ralph R, Weichselbaum, Bulent, Aydogan, Damiano, Rondelli
Publikováno v:
Leukemialymphoma. 59(7)
In this phase 1 study, we tested increasing doses of total marrow irradiation (TMI) in addition to standard intravenous melphalan at 200 mg/m
Autor:
Ralph R. Weichselbaum, Azhar Awan, Dolores Mahmud, Santosh L. Saraf, David Peace, Irum Khan, Damiano Rondelli, John G. Quigley, Karen Sweiss, Bulent Aydogan, Matthew Koshy, Nadim Mahmud, Pritesh R. Patel, Vincenzo DeMasi, Annie Oh
Publikováno v:
Biology of Blood and Marrow Transplantation. 20(12):2034-2041
Here we examined the addition of intensity-modulated total marrow irradiation (TMI) delivered using a linear accelerator to a myeloablative chemotherapy conditioning regimen before allogeneic hematopoietic stem cell transplantation (HSCT). In this ph
Autor:
Victor R. Gordeuk, Damiano Rondelli, John G. Quigley, Yi Fan Chen, Ronald Hoffman, David Peace, Irum Khan, Pritesh R. Patel, Santosh L. Saraf, Ardaman Shergill
Publikováno v:
Clinical lymphoma, myelomaleukemia. 16(6)
Background The Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) are characterized by an increased risk of thrombotic and hemorrhagic complications. Large retrospective studies have demonstrated racial disparities in MPN outcomes a